Hiroaki Akamatsu

Hiroaki Akamatsu

Wakayama Medical University - Wakayama / Japan
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 334905
和歌山県立医科大学
person_outline Hiroaki Akamatsu's MOST POPULAR ARTICLES
1-) Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung CancerTS Mok, YL Wu, MJ Ahn, MC Garassino, HR Kim, SS Ramalingam, ...New England Journal of Medicine 376 (7), 629-640, 201727452017
2-) Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumabK Sato, H Akamatsu, E Murakami, S Sasaki, K Kanai, A Hayata, ...Lung Cancer 115, 71-74, 20182982018
3-) Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysisVA Papadimitrakopoulou, TS Mok, JY Han, MJ Ahn, A Delmonte, ...Annals of Oncology 31 (11), 1536-1544, 20202022020
4-) Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array systemM Hosokawa, H Kenmotsu, Y Koh, T Yoshino, T Yoshikawa, T Naito, ...PloS one 8 (6), e67466, 20132022013
5-) Perioperative durvalumab for resectable non–small-cell lung cancerJV Heymach, D Harpole, T Mitsudomi, JM Taube, G Galffy, M Hochmair, ...New England Journal of Medicine 389 (18), 1672-1684, 20231982023